Tirzepatide for Research

What is Tirzepatide?

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

How Tirzepatide works (research mechanism)

Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Primary research applications

Weight-management research

Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research

Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies

Frequently compared with semaglutide.

Research dosing reference

Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Reconstitution & handling

Tirzepatide ships as a lyophilized (freeze-dried) powder and must be reconstituted before use in any liquid research model. Allow the vial to reach room temperature, swab the stopper, then add bacteriostatic water slowly down the inside wall of the vial - never spray it directly onto the powder. Swirl gently until dissolved; do not shake, as shaking foams the solution and stresses the peptide. The volume of water you add sets the concentration: a 5 mg vial reconstituted with 2 mL yields 2,500 mcg/mL, so 0.1 mL measures 250 mcg. A correctly reconstituted Tirzepatide solution is clear; discard if it is cloudy or shows particulate.

Storage & stability

Store un-reconstituted Tirzepatide vials refrigerated and protected from light for long-term stability; the lyophilized form is robust and tolerates shipping. After reconstitution, refrigerate at 2-8C, keep away from light, and use within the typical research window of roughly two to four weeks. The benzyl alcohol in bacteriostatic water helps inhibit microbial growth across that period. Always label reconstituted vials with the concentration and date.

Common research pairings

Studied as a standalone dual-agonist model or compared with semaglutide.

How Tirzepatide compares

Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Safety & research considerations

Supplied for research use only; not for human consumption. GI effects are noted in the incretin literature.

Sourcing, purity & Certificate of Analysis

Every lot of Tirzepatide sold by Peptides Factory Direct is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC. A Certificate of Analysis (COA) documenting these results is available on request and ties each vial to a tracked lot. Material ships nationwide to all 50 US states with cold-chain handling where appropriate and fast domestic dispatch. This documentation is what separates research-grade Tirzepatide from unverified material - quality is established before the vial ever reaches your lab.

How to order Tirzepatide for research

Tirzepatide can be ordered through the Peptides Factory Direct research portal as a one-time purchase or on a recurring research schedule (every 2 weeks, monthly, every 2 months, or every 3 months). Checkout requires confirming you are 21 or older, purchasing for laboratory research only, and that the product is not for human or animal consumption. Bulk and standing-order pricing is available - note it in your order. Open the order portal to view current research sizes and pricing.

Frequently asked questions

Related Fat Loss & Weight Management peptides

All Fat Loss & Weight Management peptides · Research guides & articles

External references: Peptides (Wikipedia) · U.S. Food and Drug Administration